Suscribirse

Sleeping with Elevated Upper Body Does Not Attenuate Acute Mountain Sickness: Pragmatic Randomized Clinical Trial - 28/09/20

Doi : 10.1016/j.amjmed.2020.01.024 
Ulrich Limper, MD a, b, Vera Fiala c, Jens Tank, MD b, Eva-Maria Elmenhorst, MD b, d, Gereon Schaelte, MD c, Ya-Yu Monica Hew, PhD b, Peter Gauger, MS b, Peter Martus, PhD e, Jens Jordan, MD b, f, 1,
a Department of Anesthesiology and Intensive Care Medicine, Merheim Medical Center, Hospitals of Cologne, University of Witten/Herdecke, Cologne, Germany 
b German Aerospace Center (DLR), Institute of Aerospace Medicine, Cologne, Germany 
c Department of Anesthesiology, Medical Faculty, University Hospital RWTH Aachen, Aachen, Germany 
d Institute for Occupational, Social and Environmental Medicine, Medical Faculty, University Hospital RWTH Aachen, Aachen, Germany 
e Institute of Medical Biometry, University of Tuebingen, Tuebingen, Germany 
f Chair of Aerospace Medicine, Medical Faculty, University of Cologne, Cologne, Germany 

Requests for reprints should be addressed to Jens Jordan, MD, German Aerospace Center (DLR), Institute of Aerospace Medicine, Linder Hoehe, Cologne D-51147, Germany.German Aerospace Center (DLR)Institute of Aerospace MedicineLinder HoeheCologneD-51147,Germany

Abstract

Purpose

Acute mountain sickness commonly occurs following ascent to high altitude and is aggravated following sleep. Cephalad fluid shifts have been implicated. We hypothesized that sleeping with the upper body elevated by 30º reduces the risk of acute mountain sickness.

Methods

In a pragmatic, randomized, observer-blinded field study at 4554 meters altitude, we investigated 134 adults aged 18-70 years with a Lake Louise score between 3 and 12 points on the evening of their arrival at the altitude. The individuals were exposed to sleeping on an inflatable cushion elevating the upper body by 30º or on a sham pillow in a horizontal position. The primary endpoint was the change in the Acute Mountain Sickness-Cerebral (AMS-C) score in the morning after sleeping at an altitude of 4554 meters compared with the evening before. Sleep efficiency was the secondary endpoint.

Results

Among 219 eligible mountaineers, 134 fulfilled the inclusion criteria and were randomized. The AMS-C score increased by 0.250 ± 0.575 in the control group and by 0.121 ± 0.679 in the intervention group (difference 0.105; 95% confidence interval, −0.098-0.308; P = .308). Oxygen saturation in the morning was 79% ± 6% in the intervention group and 78% ± 6% in the control group (P = .863). Sleep efficiency did not differ between groups (P = .115).

Conclusions

Sleeping with the upper body elevated by 30° does not lead to relevant reductions in acute mountain sickness symptoms or hypoxemia at high altitude.

El texto completo de este artículo está disponible en PDF.

Keywords : Acute mountain sickness, Altitude, Brain edema, Environmental medicine, High altitude, Mountaineering, Pulmonary, Sleep, Travel medicine


Esquema


 Trial registration: German Clinical Trial Register DRKS00012676.
 Funding: This study was supported by the programmatic funding of the German Aerospace Center (DLR) and by a grant from the German Society for Mountain- and Expedition Medicine (BExMed).
 Conflict of Interest: UL reports grants from the German Society for Mountain and Expedition Medicine (BExMed) during the conduct of the study. All other authors have nothing to disclose. UL affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
 Authorship: UL: Conceptualization, methodology, formal analysis, investigation, writing - original draft, review & editing, funding acquisition; VF: Formal analysis, investigation, writing - review and editing, project administration; JT: Investigation, project administration, provision of study materials; E-ME: Methodology, supervision, writing - review and editing; GS: Methodology, writing - review and editing, supervision; Y-YMH: Investigation, project administration; PG: Provision and design of study materials (wedges), visualization, investigation; PM: Formal analysis, methodology; programming; JJ: Supervision, writing - review and editing, funding acquisition, methodology.
 The authors declare that the data supporting the findings of this study are available within the article. Anonymized data will be shared from the corresponding author upon reasonable request from any qualified investigator.


© 2020  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 133 - N° 10

P. e584-e588 - octobre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Coronary Artery Calcium and the Age-Specific Competing Risk of Cardiovascular Versus Cancer Mortality: The Coronary Artery Calcium Consortium
  • Seamus P. Whelton, Mahmoud Al Rifai, Catherine Handy Marshall, Zeina Dardari, Leslee J. Shaw, Mouaz H. Al-Mallah, Alan Rozanski, Martin B. Mortensen, Omar Dzaye, Lydia Bazzano, Tanika N. Kelly, Kunihiro Matsushita, John A. Rumberger, Daniel S. Berman, Matthew J. Budoff, Michael D. Miedema, Khurram Nasir, Michael J. Blaha
| Artículo siguiente Artículo siguiente
  • Esophageal Tuberculosis – A Mass of Confusion
  • Bernard J. Danna, Alexander W. Harvey, Laila E. Woc-Colburn

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.